Dear E-Druggers,
In 2017 the first Lancet Commission report was published: for me the most authoritative report on Access to Medicines in the last decade.
The excellent report is still available at https://pubmed.ncbi.nlm.nih.gov/27832874/
We are now 8 years later, and it is only 5 years away from 2030, when we are supposed to have Universal Access, including access to essential medicines.
A pandemic, war and changes in international health governance have not helped.
2 billion people still have no access to essential medicines…
So it is very welcome that the Lancet has established a new Lancet Commission on Accelerating Progress on Essential Medicines has been established. The Commission will identify new evidence from the past decade, critically examining how the concept of essential medicines can be valued, how essential medicines can be financed, how innovations can be used and shared, how public capacity can be strengthened to supply and use essential medicines in a cost-effective way, and how progress can best be measured.
The Commission will organise regional roundtables with policy experts and government officials and will also invite public comments. It will provide recommendations for governments, health professionals, academics, and civil society, with special attention to the needs of LMICs.
The report will be published in 2027 to coincide with the 50th anniversary of the first WHO Model List of Essential Medicines.
Accelerating progress on essential medicines: a new Lancet Commission
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01026-8/fulltext
E-Drug will cover the progress of the Commission, and we can possibly help the Commission with our debates.
Wilbert Bannenberg
(attachments)
PIIS0140673625010268.pdf (438 KB)